In 2007 was created Mitsubishi Tanabe Pharma, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Osaka. The company was established in Asia in Japan.
The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2013. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2008.
The standard case for the fund is to invest in rounds with 8 partakers. Despite the Mitsubishi Tanabe Pharma, startups are often financed by VenGrowth Asset Management, Novo Holdings, GeneChem. The meaningful sponsors for the fund in investment in the same round are VentureLink LP, VenGrowth Asset Management, Novo Holdings.
Among the most popular portfolio startups of the fund, we may highlight Cytochroma. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Clinical Trials. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Canada.
Fund Name | Location |
AJI Capital | Huntington, New York, United States |
Brilliant Ventures | California, Santa Monica, United States |
euclid group | Japan, Tokyo |
Euro Sales Finance | England, London, United Kingdom |
Henan Guokong Fund Management | China, Henan, Zhengzhou |
Isetan Mitsukoshi Holdings | Japan, Shinjuku |
Jieyi Ziben | Beijing, Beijing, China |
Major League Baseball | New York, New York, United States |
MLS Capital Fund II | - |
Ningbo Xinrongji Touzi Youxian Gongsi | China, Ningbo, Zhejiang |
Paparelli Ventures | Atlanta, Georgia, United States |
Quoris | California, San Diego, United States |
Red Fort Capital | - |
Requus Ventures | New York, New York, United States |
Retailers lab | - |
Sembrador Capital | Chile, Santiago Metropolitan Region, Vitacura |
Sichuan Kaida Investment Development | China, Gansu, Sichuan |
SIMWON | Kyonggi-do, Seongnam, South Korea |
UMJ | Japan, Tokyo |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
$35M | 30 Jul 2008 | Ontario |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
$35M | 30 Jul 2008 | Ontario |